Co-Authors
This is a "connection" page, showing publications co-authored by Peter Cherepanov and Annachiara Rosa.
Connection Strength
1.411
-
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity. Sci Adv. 2021 05; 7(22).
Score: 0.948
-
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. Med (N Y). 2021 Sep 10; 2(9):1093-1109.e6.
Score: 0.060
-
Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection. Kidney Int Rep. 2021 Jul; 6(7):1799-1809.
Score: 0.059
-
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. Immunity. 2021 06 08; 54(6):1276-1289.e6.
Score: 0.059
-
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting. J Infect Dis. 2021 03 29; 223(6):971-980.
Score: 0.059
-
The effect of spike mutations on SARS-CoV-2 neutralization. Cell Rep. 2021 03 23; 34(12):108890.
Score: 0.058
-
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020 12 11; 370(6522):1339-1343.
Score: 0.057
-
Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):927-931.
Score: 0.056
-
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):1000.
Score: 0.056